Tradeline, Inc. | Leading-edge resources for facilities planning and management www.tradelineinc.com

Building 23


Published January 1995

Project Information
Building Owner: Amgen
Building Location: Thousand Oaks, CA USA
Project Type: New Construction
Principal Building Function: Clinical manufacturing and pharmaceutical development.
Project Delivery Method: General Contractor (GC)
Project Timeline
Jan 1995Target Completion
Last known status: Design
Construction Cost: $9,200,000
About These Cost Figures
Building Information
Project Includes: Laboratory: Wet
Pilot Plant
Process: Wet
Total GSF: 45,150
Total NSF: 33,863
Building Services: New mechanical, electrical and plumbing systems for pharmaceutical development.
Project Team
Supplier Strobic Air Corporation
Supplier - Laboratory Airflow Control Phoenix Controls Corporation
Profile Created 01/01/1995
Last Updated 04/04/2006
About the Reported Cost Figures
The cost figures reported are supplied by the firms that submitted these projects for publication, which in most cases are the designers or builders. Whereas these sources are intimately familiar with their projects, they may not be fully aware of the owners' finally-realized and recorded costs. In some cases, costs are truly and completely accounted for, and in others they represent a near approximation of the final costs. Costs have not been adjusted for year of construction, nor has any attempt been made to make regional cost adjustments.

Further, costs are not comparable on any kind of detailed standard costing model. Hence, it is possible for the cost of one building to include a steam boiler, while the cost of a comparable building might not include the boiler, if steam is being supplied from an already existing campus grid. Or, in another case, a building might include excess boiler capacity to supply steam to another building. Some submittals include fees or unusual site improvements as part of the construction costs, which others do not.
Circulate to:

[ ]

[ ]

[ ]

Notes:














Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894